"Run for Rogosin" to Benefit Kidney Disease Research and Treatment
Kidney Disease Risk Now Greater Than Risk for Having Diabetes, Coronary Heart Disease, Cancer*
NEW YORK, Sept. 17, 2013 /PRNewswire-USNewswire/ -- A 5K run/walk to raise funds for The Rogosin Institute http://www.rogosin.org/ will be held on Sunday morning, September 29, at the West Bank Cafe, owned by kidney transplant recipient, Steve Olsen, founder of the race.
The goal of this third annual "Run for Rogosin" race is to raise $100,000 for kidney disease research and treatment, including dialysis and transplantation. Donors and walk/race participants can register at First Giving http://bit.ly/1dUaR86.
Donations are requested, but not required, to enter the race. Each participant will receive a free T-shirt and complimentary brunch at the West Bank Cafe following the run/walk. Donations also welcome from non-runners.
8:00 am - Meet at West Bank Cafe, 407 West 42nd Street, (just east of 9th Avenue in Manhattan) for check in and registration, pledge payments, signing of waivers, and T-shirt pick up.
8:45 am - Group photo and walk to Pier 81 at 42nd Street, along the Hudson River
9:00 am - Start of the 5K run/walk through the Hudson River run/walk and bike path at Pier 81 at 42nd Street, down to 14th Street, turn around, finish at Pier 81
10:00 am and thereafter - Steve Olsen and Janet Momjian will welcome participants for a complimentary celebration brunch at the West Bank Cafe.
Corporate sponsors of the event are West Bank Cafe (founding sponsor), The Horace W. Goldsmith Foundation, Modell's Sporting Goods, Salveo Pharmacy, Benihana, Midwood Ambulance, and Spectra Labs, plus individuals and team members.
The Rogosin Institute
The Rogosin Institute is an independent not-for-profit treatment and research center associated with NewYork-Presbyterian Hospital (NYPH) and Weill Cornell Medical College. It is one of the nation's leading research and treatment centers for kidney disease, providing services from early stage disease to those requiring dialysis and transplantation. It also has programs in diabetes, hypertension and lipid disorders. The Institute's cancer research program began in 1995. The Rogosin Institute is unique in its combination of the best in clinical care with research into new and better ways to prevent and treat disease.
SOURCE Rogosin Institute